NCR Voyix Corporation (VYX)
NYSE: VYX
· Real-Time Price · USD
12.98
-0.11 (-0.84%)
At close: Sep 09, 2025, 3:59 PM
13.32
2.62%
Pre-market: Sep 10, 2025, 08:31 AM EDT
NCR Voyix Revenue Breakdown
Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 |
---|---|---|---|---|
All other products and services Revenue | 244M | 210M | 888M | 304M |
All other products and services Revenue Growth | +16.19% | -76.35% | +192.11% | n/a |
Recurring revenue Revenue | 422M | 407M | 1.23B | 407M |
Recurring revenue Revenue Growth | +3.69% | -66.83% | +201.47% | n/a |
Revenue by Geography
Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 |
---|---|---|---|---|
Americas (Excluding United States) Revenue | 45M | 43M | 189M | 50M |
Americas (Excluding United States) Revenue Growth | +4.65% | -77.25% | +278.00% | n/a |
Asia Pacific Revenue | 66M | 59M | 233M | 74M |
Asia Pacific Revenue Growth | +11.86% | -74.68% | +214.86% | n/a |
Emea Revenue | 153M | 132M | 444M | 130M |
Emea Revenue Growth | +15.91% | -70.27% | +241.54% | n/a |
United States Revenue | 402M | 383M | 1.25B | 457M |
United States Revenue Growth | +4.96% | -69.34% | +173.30% | n/a |
Operating Expense Breakdown
Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Selling, General, and Administrative Revenue | 107M | 115M | 119M | 114M | 116M | 98M | 277M | 350M | 333M | 292M | 264M | 254M | 299M | 302M | 185M | 291M | 300M | 235M | 341M | 254M | 233M | 255M | 358M | 273M | 254M | 252M | 228M | 226M | 261M | 245M | 256M | 220M | 228M | 230M | 248M | 225M | 229M | 224M | 254M | 224M | 339M | 225M |
Selling, General, and Administrative Revenue Growth | -6.96% | -3.36% | +4.39% | -1.72% | +18.37% | -64.62% | -20.86% | +5.11% | +14.04% | +10.61% | +3.94% | -15.05% | -0.99% | +63.24% | -36.43% | -3.00% | +27.66% | -31.09% | +34.25% | +9.01% | -8.63% | -28.77% | +31.14% | +7.48% | +0.79% | +10.53% | +0.88% | -13.41% | +6.53% | -4.30% | +16.36% | -3.51% | -0.87% | -7.26% | +10.22% | -1.75% | +2.23% | -11.81% | +13.39% | -33.92% | +50.67% | n/a |
Research and Development Revenue | 32M | 40M | 28M | 38M | 44M | 60M | 56M | 54M | 57M | 64M | 53M | 40M | 59M | 65M | 64M | 69M | 69M | 66M | 65M | 55M | 49M | 65M | 74M | 64M | 62M | 59M | 62M | 59M | 65M | 66M | 78M | 53M | 58M | 67M | 83M | 56M | 50M | 53M | 55M | 53M | 67M | 55M |
Research and Development Revenue Growth | -20.00% | +42.86% | -26.32% | -13.64% | -26.67% | +7.14% | +3.70% | -5.26% | -10.94% | +20.75% | +32.50% | -32.20% | -9.23% | +1.56% | -7.25% | 0.00% | +4.55% | +1.54% | +18.18% | +12.24% | -24.62% | -12.16% | +15.62% | +3.23% | +5.08% | -4.84% | +5.08% | -9.23% | -1.52% | -15.38% | +47.17% | -8.62% | -13.43% | -19.28% | +48.21% | +12.00% | -5.66% | -3.64% | +3.77% | -20.90% | +21.82% | n/a |